Trial Profile
Cytokine Inhibition in Chronic Fatigue Syndrome Patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Chronic fatigue syndrome; Fatigue
- Focus Therapeutic Use
- Acronyms CiCFS
- 07 Mar 2017 Primary endpoint (Fatigue severity-measured by the Checklist Individual Strength subscale (CIS-fatigue) at 4 weeks) has not been met, according to results published in the Annals of Internal Medicine Journal.
- 07 Mar 2017 Results published in the Annals of Internal Medicine Journal.
- 24 May 2016 Status changed from active, no longer recruiting to completed.